Elevance Health Inc. has shown a strong performance in the healthcare industry, leveraging its comprehensive care offerings. Despite a competitive market, it maintains a robust portfolio serving millions of individuals. The company's rebranding and strategic expansions are pivotal to its sustained growth.
The fundamental analysis indicates a strong financial stability with notable scores in Discounted Cash Flow and Return on Equity.
| Category | Score | Score Bar |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 3 | |
| Price to Book | 3 |
Historical data shows a consistent performance with a maintained overall score of 4, demonstrating stability in financial metrics.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-03 | 4 | 5 | 4 | 4 | 1 | 3 | 3 |
| 2025-12-03 | 4 | 5 | 4 | 4 | 1 | 3 | 3 |
Analyst price targets reflect optimism with the median price target slightly above current levels, indicating a potential upside.
| High | Low | Median | Consensus |
|---|---|---|---|
| 425 | 332 | 394.5 | 387.14 |
The consensus among analysts is generally positive, with a notable "Buy" sentiment driving the confidence in the stock's future performance.
| Rating | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 26 | |
| Hold | 11 | |
| Sell | 0 | |
| Strong Sell | 0 |
Elevance Health Inc. demonstrates a solid financial position with strong scores in critical areas like DCF and ROE. The company's robust business model in healthcare provides a stable revenue stream. Analyst sentiment remains positive, reflecting confidence in future growth, though competition in the healthcare market poses a potential risk. Overall, the stock appears to offer significant opportunities for long-term investors while requiring vigilance to industry dynamics.